Ensuring In-House Audit Programmes are Strategically Focused through Implementing Risk Models

Summary: 20% of all clinical trials are now subject to regulatory audits! With inspectors’ expectations continually evolving and an increasing number of regulatory warnings, relating to record keeping and informed consent, it is more important than ever to comply with GCP and be